Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Quality of Life »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Quality Control < Quality of Life < Quality-Adjusted Life Years  Facettes :

List of bibliographic references indexed by Quality of Life

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
000A90 (2019) Hongli Chen [République populaire de Chine] ; Fangxia Wang [République populaire de Chine] ; Pengyu Zhang [République populaire de Chine] ; Yilin Zhang [République populaire de Chine] ; Yinxia Chen [République populaire de Chine] ; Xiaohu Fan [République populaire de Chine] ; Xingmei Cao [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Yun Yang [République populaire de Chine] ; Baiyan Wang [République populaire de Chine] ; Bo Lei [République populaire de Chine] ; Liufang Gu [République populaire de Chine] ; Ju Bai [République populaire de Chine] ; Lili Wei [République populaire de Chine] ; Ruili Zhang [République populaire de Chine] ; Qiuchuan Zhuang [République populaire de Chine] ; Wanggang Zhang [République populaire de Chine] ; Wanhong Zhao [République populaire de Chine] ; Aili He [République populaire de Chine]Management of cytokine release syndrome related to CAR-T cell therapy.
000C44 (2019) Vibeke Strand [États-Unis] ; Sophie Dimonaco [Royaume-Uni] ; Katie Tuckwell [États-Unis] ; Micki Klearman [États-Unis] ; Neil Collinson [Royaume-Uni] ; John H. Stone [États-Unis]Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
000D78 (2019) Adriana G. Pe A-Romero [Mexique] ; Maria T. García-RomeroDiagnosis and management of linear scleroderma in children.
001031 (2019) April Zhang [États-Unis] ; James Nocton [États-Unis] ; Yvonne Chiu [États-Unis]A Case of Pansclerotic Morphea Treated With Tocilizumab.
001128 (2018) Raimon Sanmartí [Espagne] ; Virginia Ruiz-Esquide [Espagne] ; Carla Bastida [Espagne] ; Dolor Soy [Espagne]Tocilizumab in the treatment of adult rheumatoid arthritis.
001404 (2018) Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study.
001407 (2018) Mahmoud Abu-Shakra [Israël] ; Devy Zisman [Israël] ; Alexandra Balbir-Gurman [Israël] ; Howard Amital [Israël] ; Yair Levy [Israël] ; Pnina Langevitz [Israël] ; Moshe Tishler [Israël] ; Yair Molad [Israël] ; Suhail Aamar [Israël] ; Itzhak Roser [Israël] ; Nina Avshovich [Israël] ; Daphna Paran [Israël] ; Tatiana Reitblat [Israël] ; Reuven Mader ; Hillel Savin [Israël] ; Joshua Friedman [Israël] ; Nicky Lieberman [Israël] ; Sharon Ehrlich [Israël]Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis.
001728 (2017) Xavier M. Teitsma [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Michelle E A. Borm ; Lidy Hendriks ; Natasja H A M. Denissen [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas]Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy.
001765 (2017) Ethan S. Sen [Royaume-Uni] ; A V Ramanan [Royaume-Uni]Juvenile idiopathic arthritis-associated uveitis.
001838 (2017) Tanja Schj Dt J Rgensen [Danemark] ; Carl Turesson [Suède] ; Meliha Kapetanovic [Suède] ; Martin Englund [Suède] ; Aleksandra Turkiewicz [Suède] ; Robin Christensen [Danemark] ; Henning Bliddal [Danemark] ; Pierre Geborek [Suède] ; Lars Erik Kristensen [Danemark]EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
001863 (2017) Thita Pacharapakornpong [Thaïlande] ; Sakda Arj-Ong Vallibhakara [Thaïlande] ; Butsabong Lerkvaleekul [Thaïlande] ; Soamarat Vilaiyuk [Thaïlande]Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis.
001865 (2017) Rafael Alfonso-Cristancho [États-Unis] ; Nigel Armstrong [Royaume-Uni] ; Ramesh Arjunji [États-Unis] ; Rob Riemsma [Royaume-Uni] ; Gill Worthy [Royaume-Uni] ; Rita Ganguly [États-Unis] ; Jos Kleijnen [Royaume-Uni]Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis.
001869 (2017) Yusuke Miwa [Japon] ; Mayu Saito [Japon] ; Hidekazu Furuya [Japon] ; Ryo Yanai [Japon] ; Yuzo Ikari [Japon] ; Tomoki Hayashi [Japon] ; Tsuyoshi Kasama [Japon] ; Yoichi Toyoshima [Japon] ; Katsunori Inagaki [Japon]Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
001957 (2016) Ayako Nakajima[Cardiovascular diseases in rheumatoid arthritis].
001B03 (2016) Alessio Molfino [Italie] ; Maria Ida Amabile [Italie] ; Filippo Rossi Fanelli [Italie] ; Maurizio Muscaritoli [Italie]Novel therapeutic options for cachexia and sarcopenia.
001B08 (2016) Antonio Vitale [Italie] ; Donato Rigante [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Maria Teresa Bianco [Italie] ; Mauro Galeazzi [Italie] ; Florenzo Iannone [Italie] ; Luca Cantarini [Italie]New therapeutic solutions for Behçet's syndrome.
001B85 (2016) Flora Zagouri [Grèce] ; Evangelos Terpos [Grèce] ; Efstathios Kastritis [Grèce] ; Meletios A. Dimopoulos [Grèce]Emerging antibodies for the treatment of multiple myeloma.
002073 (2015) Eiichi Tanaka [Japon] ; Eisuke Inoue ; Daisuke Hoshi ; Yoko Shimizu ; Akiko Kobayashi ; Naoki Sugimoto ; Kumi Shidara ; Eri Sato ; Yohei Seto ; Ayako Nakajima ; Shigeki Momohara ; Atsuo Taniguchi ; Hisashi YamanakaCost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
002304 (2014) Alex Diamantopoulos [Éthiopie] ; A. Finckh ; T. Huizinga ; D K Sungher ; L. Sawyer ; D. Neto ; F. DejonckheereTocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.
002360 (2014) L. Traki [France] ; S. Rostom ; L. Tahiri ; R. Bahiri ; T. Harzy ; R. Abouqal ; N. Hajjaj-HassouniResponsiveness of the EuroQol EQ-5D and Hospital Anxiety and Depression Scale (HADS) in rheumatoid arthritis patients receiving tocilizumab.
002476 (2014) Jeroen P. Jansen ; Felicity Buckley [États-Unis] ; Fred Dejonckheere ; Sarika OgaleComparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Quality of Life" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Quality of Life" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Quality of Life
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021